BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9183665)

  • 61. Evi-2, a common integration site involved in murine myeloid leukemogenesis.
    Buchberg AM; Bedigian HG; Jenkins NA; Copeland NG
    Mol Cell Biol; 1990 Sep; 10(9):4658-66. PubMed ID: 2167436
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.
    Pekarsky Y; Hallas C; Isobe M; Russo G; Croce CM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2949-51. PubMed ID: 10077617
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retroviral integration in murine myeloid tumors to identify Evi-1, a novel locus encoding a zinc-finger protein.
    Copeland NG; Jenkins NA
    Adv Cancer Res; 1990; 54():141-57. PubMed ID: 2105003
    [No Abstract]   [Full Text] [Related]  

  • 64. Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development.
    Perkins AS; Mercer JA; Jenkins NA; Copeland NG
    Development; 1991 Feb; 111(2):479-87. PubMed ID: 1893871
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chromosomal abnormalities and oncogenes.
    Mitani K
    Int J Hematol; 1996 Feb; 63(2):81-93. PubMed ID: 8867720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nuclear targets for transcription regulation by oncogenes.
    Gutman A; Wasylyk B
    Trends Genet; 1991 Feb; 7(2):49-54. PubMed ID: 2035191
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of the abl oncogene in murine and human leukemias.
    Konopka JB; Witte ON
    Biochim Biophys Acta; 1985 Nov; 823(1):1-17. PubMed ID: 2996602
    [No Abstract]   [Full Text] [Related]  

  • 68. Oncogenes in human leukemias.
    Butturini A; Sthivelman E; Canaani E; Gale RP
    Cancer Invest; 1988; 6(3):305-16. PubMed ID: 2458808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular biology of the leukemias.
    Kirsch IR
    Pediatr Clin North Am; 1988 Aug; 35(4):693-722. PubMed ID: 3047650
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oncogenes and acute leukemias.
    Goh KO; Qazi R; Owens M; Herrmann M; Bennett JM
    Blood; 1984 Jan; 63(1):242. PubMed ID: 6689952
    [No Abstract]   [Full Text] [Related]  

  • 71. [Molecular mechanisms of acute leukemias].
    Hirai H
    Rinsho Ketsueki; 1997 Mar; 38(3):166-71. PubMed ID: 9095650
    [No Abstract]   [Full Text] [Related]  

  • 72. Chromosome Composition and the Leukemias.
    Can Med Assoc J; 1961 Aug; 85(7):379-80. PubMed ID: 20326862
    [No Abstract]   [Full Text] [Related]  

  • 73. Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.
    Kotaki R; Higuchi H; Ogiya D; Katahira Y; Kurosaki N; Yukihira N; Ogata J; Yamamoto H; Mohamad Alba S; Azhim A; Kitajima T; Inoue S; Morishita K; Ono K; Koyama-Nasu R; Kotani A
    Int J Hematol; 2017 Dec; 106(6):811-819. PubMed ID: 28831750
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice.
    Turcotte K; Gauthier S; Tuite A; Mullick A; Malo D; Gros P
    J Exp Med; 2005 Mar; 201(6):881-90. PubMed ID: 15781580
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Abnormal expression of Evi-1 gene in human leukemias.
    Ogawa S; Mitani K; Kurokawa M; Matsuo Y; Minowada J; Inazawa J; Kamada N; Tsubota T; Yazaki Y; Hirai H
    Hum Cell; 1996 Dec; 9(4):323-32. PubMed ID: 9183665
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
    Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
    Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome.
    Ogawa S; Kurokawa M; Tanaka T; Mitani K; Inazawa J; Hangaishi A; Tanaka K; Matsuo Y; Minowada J; Tsubota T; Yazaki Y; Hirai H
    Oncogene; 1996 Jul; 13(1):183-91. PubMed ID: 8700545
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5)(q25;q34) translocations.
    Morishita K; Parganas E; Bartholomew C; Sacchi N; Valentine MB; Raimondi SC; Le Beau MM; Ihle JN
    Oncogene Res; 1990; 5(3):221-31. PubMed ID: 2108405
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
    Mitani K
    Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.